81_FR_74665 81 FR 74458 - Short-Term Alternative Animal Models or In Vitro Tests Used To Identify Substances With the Potential To Cause Excessive Inflammation or Exaggerated Immune Responses; Request for Information

81 FR 74458 - Short-Term Alternative Animal Models or In Vitro Tests Used To Identify Substances With the Potential To Cause Excessive Inflammation or Exaggerated Immune Responses; Request for Information

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 207 (October 26, 2016)

Page Range74458-74458
FR Document2016-25924

The National Toxicology Program (NTP) at the National Institute of Environmental Health Sciences (NIEHS) requests available data and information on approaches and/or technologies currently used to identify substances with the potential to cause excessive inflammation or exaggerated immune responses leading to tissue injury when swallowed, inhaled, or absorbed through the skin. Submitted information will be used to assess the state of the science and determine technical needs for non-animal test methods that could be used to evaluate the potential of chemicals to induce inflammation and immune-related conditions.

Federal Register, Volume 81 Issue 207 (Wednesday, October 26, 2016)
[Federal Register Volume 81, Number 207 (Wednesday, October 26, 2016)]
[Notices]
[Page 74458]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-25924]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Short-Term Alternative Animal Models or In Vitro Tests Used To 
Identify Substances With the Potential To Cause Excessive Inflammation 
or Exaggerated Immune Responses; Request for Information

SUMMARY: The National Toxicology Program (NTP) at the National 
Institute of Environmental Health Sciences (NIEHS) requests available 
data and information on approaches and/or technologies currently used 
to identify substances with the potential to cause excessive 
inflammation or exaggerated immune responses leading to tissue injury 
when swallowed, inhaled, or absorbed through the skin. Submitted 
information will be used to assess the state of the science and 
determine technical needs for non-animal test methods that could be 
used to evaluate the potential of chemicals to induce inflammation and 
immune-related conditions.

DATES: Receipt of information: Deadline is December 12, 2016.

ADDRESSES: Data and information should be submitted electronically at 
http://ntp.niehs.nih.gov/go/input.

FOR FURTHER INFORMATION CONTACT: Dr. Dori Germolec, Toxicology Branch, 
Division of NTP, NIEHS; email: [email protected]; telephone: (919) 
541-3230.

SUPPLEMENTARY INFORMATION: 
    Background: NTP has an interest in developing more efficient and 
scalable test platforms to provide the scientific basis for predictive 
models of chemical effects on human disease. Short-term toxicity tests 
may be conducted to determine the potential for a single or short-term 
dose of a substance to cause inflammation-related responses or impact 
local and systemic immune function when inhaled (inhalation toxicity 
testing), swallowed (oral toxicity testing), or absorbed through the 
skin (dermal toxicity testing). A number of observations support a role 
for environmental influences on inflammatory and immune-related 
diseases such as diabetes. One specific use of information received in 
response to this request is to assist NTP in identifying in vitro or 
alternative animal model screens that might be used to assess the 
potential for chemicals to cause outcomes related to Type 1 diabetes. 
In addition, information received from this request will provide 
fundamental knowledge on the use of these in vitro platforms for 
identifying environmental triggers of excessive inflammation and 
exaggerated immune responses that could lead to tissue injury.
    Request for Information: NTP requests available data and 
information on approaches and/or technologies currently used to 
identify substances with the potential to cause excessive inflammation 
or exaggerated immune responses leading to tissue injury. Respondents 
should provide information on any activities relevant to the 
development or validation of alternatives to in vivo tests currently 
used in the assessment of immune toxicity and autoimmunity.
    Respondents to this request for information should include their 
name, affiliation (if applicable), mailing address, telephone, email, 
and sponsoring organization (if any) with their communications. The 
deadline for receipt of the requested information is December 12, 2016.
    Responses to this request are voluntary. No proprietary, 
classified, confidential, or sensitive information should be included 
in responses. This request for information is for planning purposes 
only and is not a solicitation for applications or an obligation on the 
part of the U.S. Government to provide support for any ideas identified 
in response to the request. Please note that the U.S. Government will 
not pay for the preparation of any information submitted or for its use 
of that information.
    Background Information on NTP: NTP is an interagency program 
established in 1978 (43 FR 53060) to strengthen the Department's 
activities in toxicology research and testing and to develop and 
validate new and better testing methods. Other activities of the 
program focus on strengthening the science base in toxicology and 
providing information about potentially toxic chemicals to health-
regulatory and research agencies, scientific and medical communities, 
and the public. NTP is located administratively at the NIEHS. 
Information about NIEHS and NTP is available at http://www.niehs.nih.gov and http://ntp.niehs.nih.gov, respectively.

    Dated: October 20, 2016.
John R. Bucher,
Associate Director, National Toxicology Program.
[FR Doc. 2016-25924 Filed 10-25-16; 8:45 am]
 BILLING CODE 4140-01-P



                                                    74458                     Federal Register / Vol. 81, No. 207 / Wednesday, October 26, 2016 / Notices

                                                    appointed for the Committee leadership.                 technical needs for non-animal test                   receipt of the requested information is
                                                    The Committee structure has been                        methods that could be used to evaluate                December 12, 2016.
                                                    expanded to include ex-officio                          the potential of chemicals to induce                     Responses to this request are
                                                    representation from the Department of                   inflammation and immune-related                       voluntary. No proprietary, classified,
                                                    Veterans Affairs (VA). The VA has the                   conditions.                                           confidential, or sensitive information
                                                    largest conglomerate of hospitals in the                                                                      should be included in responses. This
                                                                                                            DATES:   Receipt of information: Deadline
                                                    United States. The agency has                                                                                 request for information is for planning
                                                                                                            is December 12, 2016.
                                                    responsibility for the largest patient                                                                        purposes only and is not a solicitation
                                                    population that uses the largest quantity               ADDRESSES: Data and information
                                                                                                                                                                  for applications or an obligation on the
                                                    of blood and tissue products in the                     should be submitted electronically at
                                                                                                                                                                  part of the U.S. Government to provide
                                                    United States. Therefore, it was                        http://ntp.niehs.nih.gov/go/input.
                                                                                                                                                                  support for any ideas identified in
                                                    determined that involvement of the VA                   FOR FURTHER INFORMATION CONTACT: Dr.                  response to the request. Please note that
                                                    would be beneficial to the ACBTSA for                   Dori Germolec, Toxicology Branch,                     the U.S. Government will not pay for
                                                    ensuring that the Committee properly                    Division of NTP, NIEHS; email:                        the preparation of any information
                                                    addresses current issues and concerns                   germolec@niehs.nih.gov; telephone:                    submitted or for its use of that
                                                    regarding blood and tissue safety and                   (919) 541–3230.                                       information.
                                                    availability.                                           SUPPLEMENTARY INFORMATION:                               Background Information on NTP: NTP
                                                       On October 5, 2016, the new charter                     Background: NTP has an interest in                 is an interagency program established in
                                                    for the ACBTSA was approved by the                      developing more efficient and scalable                1978 (43 FR 53060) to strengthen the
                                                    Secretary of Health and Human                           test platforms to provide the scientific              Department’s activities in toxicology
                                                    Services, and it was filed with the                     basis for predictive models of chemical               research and testing and to develop and
                                                    appropriate Congressional committees                    effects on human disease. Short-term                  validate new and better testing methods.
                                                    and the Library of Congress on October                  toxicity tests may be conducted to                    Other activities of the program focus on
                                                    9, 2016. ACBTSA is authorized to                        determine the potential for a single or               strengthening the science base in
                                                    operate until October 9, 2018. A copy of                short-term dose of a substance to cause               toxicology and providing information
                                                    the charter can be obtained on the                      inflammation-related responses or                     about potentially toxic chemicals to
                                                    ACBTSA Web site at http://                              impact local and systemic immune                      health-regulatory and research agencies,
                                                    www.hhs.gov/ash/bloodsafety.                            function when inhaled (inhalation
                                                       Copies of the charters for the                                                                             scientific and medical communities,
                                                                                                            toxicity testing), swallowed (oral                    and the public. NTP is located
                                                    designated committees also can be
                                                                                                            toxicity testing), or absorbed through the            administratively at the NIEHS.
                                                    obtained by accessing the FACA
                                                                                                            skin (dermal toxicity testing). A number              Information about NIEHS and NTP is
                                                    database that is maintained by the
                                                                                                            of observations support a role for                    available at http://www.niehs.nih.gov
                                                    Committee Management Secretariat
                                                                                                            environmental influences on                           and http://ntp.niehs.nih.gov,
                                                    under the General Services
                                                                                                            inflammatory and immune-related                       respectively.
                                                    Administration. The Web site address
                                                                                                            diseases such as diabetes. One specific                 Dated: October 20, 2016.
                                                    for the FACA database is http://
                                                                                                            use of information received in response
                                                    facadatabase.gov/.                                                                                            John R. Bucher,
                                                                                                            to this request is to assist NTP in
                                                      Dated: October 20, 2016.                              identifying in vitro or alternative animal            Associate Director, National Toxicology
                                                    Karen B. DeSalvo,                                                                                             Program.
                                                                                                            model screens that might be used to
                                                                                                                                                                  [FR Doc. 2016–25924 Filed 10–25–16; 8:45 am]
                                                    Acting Assistant Secretary for Health.                  assess the potential for chemicals to
                                                                                                            cause outcomes related to Type 1                      BILLING CODE 4140–01–P
                                                    [FR Doc. 2016–25916 Filed 10–25–16; 8:45 am]
                                                    BILLING CODE 4150–28–P                                  diabetes. In addition, information
                                                                                                            received from this request will provide
                                                                                                            fundamental knowledge on the use of                   DEPARTMENT OF HEALTH AND
                                                    DEPARTMENT OF HEALTH AND                                these in vitro platforms for identifying              HUMAN SERVICES
                                                    HUMAN SERVICES                                          environmental triggers of excessive                   National Institutes of Health
                                                                                                            inflammation and exaggerated immune
                                                    National Institutes of Health                           responses that could lead to tissue                   National Institute of Allergy and
                                                                                                            injury.                                               Infectious Diseases; Notice of Closed
                                                    Short-Term Alternative Animal Models
                                                                                                               Request for Information: NTP requests              Meetings
                                                    or In Vitro Tests Used To Identify
                                                                                                            available data and information on
                                                    Substances With the Potential To                                                                                Pursuant to section 10(d) of the
                                                                                                            approaches and/or technologies
                                                    Cause Excessive Inflammation or                                                                               Federal Advisory Committee Act, as
                                                                                                            currently used to identify substances
                                                    Exaggerated Immune Responses;                                                                                 amended (5 U.S.C. App.), notice is
                                                                                                            with the potential to cause excessive
                                                    Request for Information                                                                                       hereby given of the following meetings.
                                                                                                            inflammation or exaggerated immune
                                                    SUMMARY:   The National Toxicology                      responses leading to tissue injury.                     The meetings will be closed to the
                                                    Program (NTP) at the National Institute                 Respondents should provide                            public in accordance with the
                                                    of Environmental Health Sciences                        information on any activities relevant to             provisions set forth in sections
                                                    (NIEHS) requests available data and                     the development or validation of                      552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                                    information on approaches and/or                        alternatives to in vivo tests currently               as amended. The grant applications and
asabaliauskas on DSK3SPTVN1PROD with NOTICES




                                                    technologies currently used to identify                 used in the assessment of immune                      the discussions could disclose
                                                    substances with the potential to cause                  toxicity and autoimmunity.                            confidential trade secrets or commercial
                                                    excessive inflammation or exaggerated                      Respondents to this request for                    property such as patentable material,
                                                    immune responses leading to tissue                      information should include their name,                and personal information concerning
                                                    injury when swallowed, inhaled, or                      affiliation (if applicable), mailing                  individuals associated with the grant
                                                    absorbed through the skin. Submitted                    address, telephone, email, and                        applications, the disclosure of which
                                                    information will be used to assess the                  sponsoring organization (if any) with                 would constitute a clearly unwarranted
                                                    state of the science and determine                      their communications. The deadline for                invasion of personal privacy.


                                               VerDate Sep<11>2014   18:25 Oct 25, 2016   Jkt 241001   PO 00000   Frm 00068   Fmt 4703   Sfmt 4703   E:\FR\FM\26OCN1.SGM   26OCN1



Document Created: 2016-10-26 02:17:16
Document Modified: 2016-10-26 02:17:16
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesReceipt of information: Deadline is December 12, 2016.
ContactDr. Dori Germolec, Toxicology Branch, Division of NTP, NIEHS; email: [email protected]; telephone: (919) 541-3230.
FR Citation81 FR 74458 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR